Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

Cited In for PubMed (Select 17631150)

1.

Effect of Helicobacter pylori Eradication on TLR2 and TLR4 Expression in Patients with Gastric Lesions.

Cadamuro AC, Rossi AF, Matos Biselli-Périco J, Fucuta Pereira P, Do Vale EP, Acayaba R, Leite KR, Goloni-Bertollo EM, Silva AE.

Mediators Inflamm. 2015;2015:481972. doi: 10.1155/2015/481972. Epub 2015 Mar 22.

2.

Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.

Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF.

Cancer Lett. 2014 Dec 1;355(1):106-12. doi: 10.1016/j.canlet.2014.09.010. Epub 2014 Sep 11.

PMID:
25218349
3.

An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design.

Ardito M, Fueyo J, Tassone R, Terry F, DaSilva K, Zhang S, Martin W, De Groot AS, Moss SF, Moise L.

Immunome Res. 2011;7(2). pii: http://omicsonline.org/search-related-journal-articles.php.

4.

Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori.

Gobert AP, Verriere T, Asim M, Barry DP, Piazuelo MB, de Sablet T, Delgado AG, Bravo LE, Correa P, Peek RM Jr, Chaturvedi R, Wilson KT.

J Immunol. 2014 Sep 15;193(6):3013-22. doi: 10.4049/jimmunol.1401075. Epub 2014 Aug 8.

PMID:
25108023
5.

Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection.

Carbo A, Olivares-Villagómez D, Hontecillas R, Bassaganya-Riera J, Chaturvedi R, Piazuelo MB, Delgado A, Washington MK, Wilson KT, Algood HM.

MBio. 2014 Jul 22;5(4):e01243-14. doi: 10.1128/mBio.01243-14.

6.

Molecular pathogenesis of cholangiocarcinoma.

Rizvi S, Gores GJ.

Dig Dis. 2014;32(5):564-9. doi: 10.1159/000360502. Epub 2014 Jul 14. Review.

PMID:
25034289
7.

At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Hardbower DM, Peek RM Jr, Wilson KT.

J Leukoc Biol. 2014 Aug;96(2):201-12. doi: 10.1189/jlb.4BT0214-099R. Epub 2014 May 27. Review.

PMID:
24868089
8.

Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy.

Uno K, Kato K, Shimosegawa T.

World J Gastroenterol. 2014 May 14;20(18):5244-51. doi: 10.3748/wjg.v20.i18.5244. Review.

9.

Differences in the antigens of Helicobacter pylori strains influence on the innate immune response in the in vitro experiments.

Skvarc M, Kopitar AN, Kos J, Obermajer N, Tepes B.

Mediators Inflamm. 2014;2014:287531. doi: 10.1155/2014/287531. Epub 2014 Jan 29.

10.

Exploring alternative treatments for Helicobacter pylori infection.

Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF, Romero I.

World J Gastroenterol. 2014 Feb 14;20(6):1450-69. doi: 10.3748/wjg.v20.i6.1450. Review.

11.

Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Cadamuro AC, Rossi AF, Maniezzo NM, Silva AE.

World J Gastroenterol. 2014 Feb 14;20(6):1424-37. doi: 10.3748/wjg.v20.i6.1424. Review.

12.

Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation.

Queiroz DM, Rocha AM, Crabtree JE.

Gut Microbes. 2013 Nov-Dec;4(6):494-504. doi: 10.4161/gmic.26277. Epub 2013 Aug 28. Review.

13.

Iron status and Helicobacter pylori infection in symptomatic children: an international multi-centered study.

Queiroz DM, Harris PR, Sanderson IR, Windle HJ, Walker MM, Rocha AM, Rocha GA, Carvalho SD, Bittencourt PF, de Castro LP, Villagrán A, Serrano C, Kelleher D, Crabtree JE.

PLoS One. 2013 Jul 4;8(7):e68833. doi: 10.1371/journal.pone.0068833. Print 2013.

14.

Spermine oxidase is a regulator of macrophage host response to Helicobacter pylori: enhancement of antimicrobial nitric oxide generation by depletion of spermine.

Chaturvedi R, Asim M, Barry DP, Frye JW, Casero RA Jr, Wilson KT.

Amino Acids. 2014 Mar;46(3):531-42. doi: 10.1007/s00726-013-1531-z. Epub 2013 Jul 3.

15.

Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer?

Hardbower DM, de Sablet T, Chaturvedi R, Wilson KT.

Gut Microbes. 2013 Nov-Dec;4(6):475-81. doi: 10.4161/gmic.25583. Epub 2013 Jun 28. Review.

16.

Helicobacter pylori infection inhibits phagocyte clearance of apoptotic gastric epithelial cells.

Bimczok D, Smythies LE, Waites KB, Grams JM, Stahl RD, Mannon PJ, Peter S, Wilcox CM, Harris PR, Das S, Ernst PB, Smith PD.

J Immunol. 2013 Jun 15;190(12):6626-34. doi: 10.4049/jimmunol.1203330. Epub 2013 May 17.

17.

Helicobacter pylori and Gastric Inflammation: Role of MUC1 Mucin.

Lillehoj EP, Guang W, Ding H, Czinn SJ, Blanchard TG.

J Pediatr Biochem. 2012 Jul 1;2(3):125-132.

18.

Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection.

Yang JC, Yang HC, Shun CT, Wang TH, Chien CT, Kao JY.

Evid Based Complement Alternat Med. 2013;2013:248585. doi: 10.1155/2013/248585. Epub 2013 Apr 11.

19.

The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden.

Horvath DJ Jr, Radin JN, Cho SH, Washington MK, Algood HM.

PLoS One. 2013;8(3):e60363. doi: 10.1371/journal.pone.0060363. Epub 2013 Mar 22.

20.

Increased gastric IL-1β concentration and iron deficiency parameters in H. pylori infected children.

Queiroz DM, Rocha AM, Melo FF, Rocha GA, Teixeira KN, Carvalho SD, Bittencourt PF, Castro LP, Crabtree JE.

PLoS One. 2013;8(2):e57420. doi: 10.1371/journal.pone.0057420. Epub 2013 Feb 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk